A Phase 2 RCT Study of CX-8998 for Essential Tremor
Public ClinicalTrials.gov record NCT03101241. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study of CX-8998 for Essential Tremor
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a multicenter, double-blind, placebo-controlled, parallel-group study consisting of a screening period of up to 4 weeks (with the exception of participants on primidone at baseline who will be allowed 6 weeks of screening to allow for safe discontinuation). Screening results from all patients meeting the eligibility requirements will be further assessed by the sponsor medical personnel for final approval of suitability for inclusion in the study. Randomized participants will enter a 4 week double-blind dose-titration treatment period, followed by a 1 week safety follow-up period following the last dose of study medication, and a scheduled follow-up safety telephone call one week later.
Study identification
- NCT ID
- NCT03101241
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 95 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 29, 2017 (Actual)
- Primary completion
- Jul 16, 2018 (Actual)
- Completion
- Jul 16, 2018 (Actual)
- Last update posted
- Nov 23, 2021
2017 – 2018
United States locations
- U.S. sites
- 22
- U.S. states
- 15
- U.S. cities
- 21
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Tucson Neuroscience Research | Tucson | Arizona | 85710 | — |
| Woodland International Research Group | Little Rock | Arkansas | 72211 | — |
| Woodland Research Northwest | Rogers | Arkansas | 72758 | — |
| University of California San Diego | La Jolla | California | 92093 | — |
| Pacific Research Network | San Diego | California | 92103 | — |
| Parkinson's Disease and Movement Disorders Center of Boca Raton | Boca Raton | Florida | 33486 | — |
| University of South Florida | Tampa | Florida | 33612 | — |
| Emory University School of Medicine | Atlanta | Georgia | 30329 | — |
| Meridian Neurology Clinical Research | Savannah | Georgia | 31406 | — |
| Northwestern Medical Group | Chicago | Illinois | 60611 | — |
| University of Kansas Medical Center | Kansas City | Kansas | 66160 | — |
| Boston University Medical Center | Boston | Massachusetts | 02118 | — |
| University of Michigan | Ann Arbor | Michigan | 48109 | — |
| Quest Research Institute | Farmington Hills | Michigan | 48334 | — |
| Henry Ford Hospital West Bloomfield | West Bloomfield | Michigan | 48322 | — |
| Washington University School of Medicine | St Louis | Missouri | 63110 | — |
| St. Louis Clinical Trials | St Louis | Missouri | 63141 | — |
| Columbia University | New York | New York | 10032 | — |
| Wake Research Associates, LLC | Raleigh | North Carolina | 27612 | — |
| Midwest Clinical Research Center | Dayton | Ohio | 45417 | — |
| Vanderbilt University | Nashville | Tennessee | 37232 | — |
| Houston Methodist Neurological Institute | Houston | Texas | 77030 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03101241, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 23, 2021 · Synced Oct 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03101241 live on ClinicalTrials.gov.